Conn’s syndrome is a hormonal condition that causes the adrenal glands to make too much aldosterone. It often leads to high blood pressure and low potassium, so people with Conn’s syndrome may feel muscle cramps, weakness, headaches, or thirst. Adults are most commonly affected, and the condition can be found on one side from a small adrenal tumor or affect both glands. Conn’s syndrome is long term but treatable, and most people live a normal lifespan with proper care. Treatment often includes blood pressure medicines like mineralocorticoid blockers, potassium supplements, and sometimes surgery to remove the overactive adrenal gland.
Overview
Conn's syndromeSymptoms
Conn's syndrome symptoms often stem from high blood pressure: headaches, blurred vision, and shortness of breath. Low potassium can cause muscle weakness, cramps, tingling, thirst, and frequent urination. Many feel no symptoms beyond hard-to-control hypertension.
Outlook and prognosis
Most people with Conn’s syndrome do well once the extra aldosterone is controlled, often with minimally invasive surgery or targeted medicines. Blood pressure and potassium levels usually improve, lowering risks to the heart, kidneys, and stroke. Ongoing follow-up helps catch relapses early.
Causes and risk factors
Conn's syndrome usually stems from an adrenal aldosterone‑producing tumor or both glands becoming overactive; rarely, it’s inherited. Risk is higher with resistant hypertension, low potassium, an adrenal mass, sleep apnea, or family history of early hypertension; high‑salt intake worsens severity.
Genetic influences
Genetics plays a smaller role in Conn’s syndrome than in many endocrine conditions. Most cases arise from acquired adrenal changes, but certain gene mutations in adrenal cells can drive hormone overproduction. Rarely, inherited forms cause early-onset or bilateral disease.
Diagnosis
Doctors suspect Conn's syndrome when high blood pressure and low potassium persist. Diagnosis of Conn's syndrome relies on a blood test showing a high aldosterone‑to‑renin ratio, suppression tests, adrenal imaging (CT), and adrenal vein sampling to pinpoint the overactive gland.
Treatment and drugs
Conn’s syndrome is treated by correcting the hormone imbalance and protecting the heart, kidneys, and blood vessels. Many do well with surgery to remove an overactive adrenal gland; others use targeted medicines that block aldosterone plus salt-sensitive blood pressure control.
Symptoms
Conn's syndrome can show up gradually, often through hard-to-control high blood pressure and symptoms caused by low potassium. You might notice small changes at first, like muscle cramps, fatigue, or needing to urinate more often. Early symptoms of Conn's syndrome are easy to overlook, so many people find out only after routine tests point to an issue.
Blood pressure stays high and can be tough to control, sometimes even with several medicines. This may be the first clue to Conn's syndrome. Headaches or brief vision changes can accompany spikes.
Pressure-like headaches or lightheadedness can happen when blood pressure rises. These episodes may come in waves. They often improve as blood pressure comes under control.
Low potassium can make muscles feel weak or heavy. Climbing stairs or lifting bags can feel harder than usual. Weakness can fluctuate over hours to days.
Painful cramps or spasms in the legs, hands, or feet are common. They may strike at night or after exercise. They usually ease once potassium levels are back in range.
How people usually first notice Conn's syndrome?
Many people first notice Conn’s syndrome when their blood pressure stays high despite multiple medications, sometimes causing headaches, vision changes, or a pounding heartbeat. Another early clue is low potassium, which can lead to muscle cramps, weakness, tingling, or frequent urination; this is often found on routine blood tests before symptoms are obvious. For many, the first signs of Conn’s syndrome appear as hard‑to‑control hypertension with or without low potassium, prompting a doctor to check hormone levels and confirm the diagnosis.
Types of Conn's syndrome
Conn's syndrome, also known medically as primary aldosteronism, has a few well-recognized variants that differ in cause, hormone pattern, and how symptoms show up day to day. People may notice different sets of symptoms depending on their situation. Some variants drive high blood pressure that’s hard to control, while others cause low potassium with muscle cramps, tingling, or fatigue. Knowing the types of Conn’s syndrome can help explain why symptoms and test results vary and guide treatment choices.
Unilateral adenoma
A single benign adrenal tumor makes excess aldosterone from one gland. This often causes resistant high blood pressure and low potassium that may fluctuate. Surgery to remove the overactive gland can be curative in many.
Bilateral hyperplasia
Both adrenal glands are overactive without a single dominant tumor. High blood pressure is common, and potassium may be normal or only mildly low. Medicines that block aldosterone are the mainstay for this type of Conn's syndrome.
Familial hyperaldosteronism
Inherited forms cause lifelong aldosterone overproduction, sometimes starting young. Family history of early high blood pressure or strokes can be a clue. Types of Conn's syndrome in this group include forms that respond well to specific medications.
Aldosterone-producing carcinoma
Rare adrenal cancer produces very high aldosterone levels. Symptoms can be more severe, with difficult-to-control blood pressure and marked potassium loss. Treatment focuses on surgery and oncology care.
What genetics can tell you about symptoms
Certain variants in the KCNJ5, ATP1A1, ATP2B3, and CACNA1D genes can make adrenal cells overproduce aldosterone, leading to high blood pressure, headaches, muscle weakness, or cramps. Some variants, like KCNJ5, more often cause larger adrenal nodules and earlier symptoms.
Causes and risk factors
The most common causes of Conn's syndrome are a small benign tumor in one adrenal gland or overactive adrenal glands on both sides.
A rare inherited form can run in families because of a gene change.
It is more likely in people with long‑standing or hard‑to‑control high blood pressure, especially when it starts at a young age.
Obesity, sleep apnea, and a high‑salt diet can raise the chance or make the condition more severe.
Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Conn's syndrome (primary aldosteronism) can push blood pressure higher and sometimes cause muscle cramps or fatigue from low potassium, which can affect everyday routines. If you’ve noticed early symptoms of Conn's syndrome like hard-to-control blood pressure, knowing what increases risk can guide timely testing. Doctors often group risks into internal (biological) and external (environmental). Below are the main biological factors known to raise the likelihood of this condition.
A small benign growth in one adrenal gland can produce extra aldosterone. This biological change drives Conn's syndrome in many people.
When both adrenal glands are overactive, they release too much aldosterone. This pattern can lead to Conn's syndrome.
Nodules seen on CT or MRI for other reasons sometimes make aldosterone. If you also have high blood pressure, doctors may check for Conn's syndrome.
The likelihood of primary aldosteronism rises in midlife. Many diagnoses occur between ages 30 and 60.
Genetic risk factors
Genetic factors play a clear role in Conn's syndrome (primary hyperaldosteronism), from inherited forms that run in families to changes that arise only in adrenal gland cells. These changes usually affect channels or pumps that control salt and calcium, and that drives excess aldosterone. Genetic clues can be especially helpful when early symptoms of Conn's syndrome—such as stubborn high blood pressure or low potassium—haven’t fully declared themselves. Risk is not destiny—it varies widely between individuals.
Somatic adrenal mutations: A large share of cases comes from changes that arise only in adrenal gland cells, often within small benign tumors or cell clusters. These changes (commonly in KCNJ5, CACNA1D, ATP1A1, or ATP2B3) disrupt how salts and calcium move, pushing aldosterone too high. They are acquired, not inherited.
FH-I (GRA): This inherited form, also called glucocorticoid-remediable hyperaldosteronism, is passed in families in an autosomal dominant pattern. A gene fusion makes the adrenal respond to a stress-hormone signal by making too much aldosterone, sometimes causing early severe hypertension. A genetic test can confirm the diagnosis and guide care.
FH-II: Often linked to changes in a chloride channel gene (CLCN2), this type can cause aldosterone overproduction from one or both adrenal glands. Onset ranges from teen years to adulthood and may vary widely even within a family. Genetic testing can help identify relatives at risk.
FH-III: Caused by inherited changes in KCNJ5, this form often starts in childhood and can be more severe. Both adrenal glands may enlarge and produce excess aldosterone. Early specialist care is important to prevent complications.
FH-IV: Changes in a calcium channel gene (CACNA1H) can lead to variable, sometimes milder aldosterone excess. Some family members have high blood pressure while others have few problems. Not everyone with the variant develops Conn's syndrome.
CACNA1D syndrome: Very rare changes in CACNA1D can cause aldosteronism with seizures and developmental differences, often from a new (de novo) variant. This pattern does not usually run in families. Recognition matters because the adrenal and neurologic features may need coordinated care.
Family history: Having a parent or sibling with a confirmed familial hyperaldosteronism raises your chance of Conn's syndrome. Genetic counseling and testing can clarify who in the family carries the variant. Knowing this can support earlier checks and treatment.
Lifestyle risk factors
Conn's syndrome (primary hyperaldosteronism) stems mainly from adrenal causes, but daily habits can intensify its high blood pressure and low potassium problems. In practice, lifestyle risk factors for Conn's syndrome influence symptom severity, treatment response, and long-term heart and kidney risks. The elements below focus on diet, activity, and other habits that can worsen or help control this condition.
Excess sodium amplifies aldosterone’s effects, driving higher blood pressure and potassium loss. Cutting back on salt can lower blood pressure and may reduce muscle cramps and fatigue linked to low potassium.
Skimping on potassium-rich foods can worsen aldosterone-driven potassium wasting and symptoms like weakness or palpitations. Guided increases in dietary potassium (when safe with your clinician) may help stabilize levels.
Natural licorice and some licorice-flavored teas/candies mimic mineralocorticoid action and can intensify hypertension and hypokalemia. Avoiding glycyrrhizin-containing licorice helps prevent misleading spikes in blood pressure and potassium loss.
Heavy drinking raises blood pressure and can aggravate arrhythmias, which are more likely when potassium is low. Limiting alcohol supports steadier blood pressure and safer potassium control.
Risk prevention
Conn’s syndrome develops inside the adrenal glands, so there’s no proven way to stop it from starting. What you can do is lower the chance of long-term problems by catching it early and protecting your heart, blood vessels, and kidneys. Prevention is about lowering risk, not eliminating it completely. Regular check-ins make a difference because early symptoms of Conn’s syndrome can be subtle—think hard-to-control blood pressure, headaches, or muscle cramps.
Ask for testing if blood pressure stays high despite 3 medicines, if potassium runs low, or if an adrenal lump was found. Screening also makes sense with early strokes in the family or high blood pressure that started young.
If you were diagnosed at a young age or have a family history of early strokes, discuss screening first-degree relatives. Finding Conn’s syndrome sooner can prevent years of strain on the heart and kidneys.
Lower-salt eating eases the blood-pressure pull of excess aldosterone. Cooking more at home and choosing fewer highly processed foods can help.
Foods rich in potassium can steady blood pressure and muscle function if your levels are low. Check with your doctor first, especially if you’re on medicines that can raise potassium after treatment starts.
Transmission
Conn's syndrome is not contagious—you can’t catch it or pass it on through kissing, sharing food, or everyday contact. In most people, it arises because one or both adrenal glands make too much aldosterone on their own, not from any exposure or infection. Rarely, there are inherited forms; if a parent carries the gene change, each child has about a 1 in 2 (50%) chance to inherit it—this is how Conn’s syndrome is inherited in those rare families. When several relatives develop high blood pressure at a young age or have low potassium, doctors may suggest screening of close family members for these uncommon familial types.
When to test your genes
Conn’s syndrome (primary aldosteronism) is worth genetic testing if it’s diagnosed before age 35, appears in both adrenal glands, runs in families, or comes with low potassium or severe/resistant hypertension. Testing can guide targeted treatment and screening for relatives. Ask your clinician about genetic panels when planning surgery or lifelong medication.
Diagnosis
Living with hard-to-control blood pressure, headaches, or muscle cramps can raise suspicion for a hormone issue behind the numbers. Doctors usually begin with targeted blood tests and a review of medicines that might affect results. From there, how Conn's syndrome is diagnosed typically involves a screening test, a confirmatory test, and imaging to see whether one or both adrenal glands are involved.
Providers look for high readings that stay elevated despite lifestyle steps or multiple medications. Patterns like early-onset hypertension or resistant hypertension raise suspicion for Conn's syndrome.
Some drugs change test accuracy, especially certain blood pressure medicines and licorice products. Your care team may adjust or temporarily switch medications to prepare for testing.
A simple blood test checks potassium and sometimes sodium and bicarbonate levels. Low potassium or metabolic alkalosis can support the suspicion but are not required to diagnose Conn's syndrome.
This screening test measures the hormone aldosterone and the enzyme renin, then compares them. A high ratio suggests excess aldosterone production and points toward Conn's syndrome.
Stages of Conn's syndrome
Conn's syndrome does not have defined progression stages. It usually causes ongoing high blood pressure and sometimes low potassium because of too much aldosterone, and doctors track it with tests rather than a stepwise decline; early symptoms of Conn's syndrome often look the same as common high blood pressure. Different tests may be suggested to help confirm the diagnosis and guide treatment. This often starts with blood tests that compare aldosterone and renin, then confirmatory checks and an adrenal scan if needed; in some cases, a specialized catheter test can show which adrenal gland is overactive so surgery can be planned, and follow-up focuses on blood pressure, potassium levels, and how well treatment is working.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Conn’s syndrome (primary aldosteronism), blood pressure and potassium levels improve significantly once the extra aldosterone is controlled—either with a targeted medicine (like an aldosterone-blocking pill) or surgery to remove an overactive adrenal nodule. Early care can make a real difference, because years of untreated high blood pressure can strain the heart, kidneys, eyes, and blood vessels. People sometimes notice day-to-day wins after treatment—fewer headaches, less muscle cramping, and steadier energy—though it may take weeks to months to see the full effect on blood pressure and medication needs.
Doctors call this the prognosis—a medical word for likely outcomes. Overall survival for people with Conn’s syndrome is good, especially when the condition is identified and treated; the main risks come from long-standing hypertension and low potassium rather than the hormone problem itself. If an adrenal adenoma is the cause and surgery is an option, many see major blood pressure improvement and some can reduce or even stop other blood pressure drugs; others still need medicines but usually at lower doses. With medication-based treatment, blood pressure often comes under better control and potassium stabilizes, lowering the risk of stroke, heart attack, abnormal heart rhythms, and kidney disease.
Everyone’s journey looks a little different. Age, how long blood pressure has been high, other conditions like diabetes or sleep apnea, and whether one or both adrenal glands are involved all shape the long-term outlook. Ask about early warning signs and what steps to take if they appear, such as sudden spikes in blood pressure, muscle weakness, or palpitations. If you’re wondering about early symptoms of Conn’s syndrome that predict outcomes, talk with your care team—sometimes the severity at diagnosis helps guide expectations. Regular follow-up, lifestyle changes, and sticking with the treatment plan offer the best chance to protect the heart and kidneys over time.
Long-term effects
Conn's syndrome can quietly push blood pressure up for years, which can strain the heart, blood vessels, and kidneys. Long-term effects vary widely, and they depend on how long aldosterone has been high and how well it’s brought under control. For many, treating the source improves potassium levels and lowers risks, but some changes may linger. Outlook tends to be better when the condition is found earlier and managed promptly.
Blood pressure can stay elevated and stiffen arteries over time. This can lead to heart muscle thickening and higher risks of stroke and heart attack.
Extra aldosterone raises the chance of atrial fibrillation and other rhythm problems. People with Conn's syndrome may notice palpitations or fluttering that comes and goes.
Years of high aldosterone can stress the kidneys, first causing over‑filtration and later a gradual decline in function. Conn's syndrome is linked with more protein in the urine and a higher risk of chronic kidney disease.
Muscle weakness, cramps, or fatigue can flare when potassium drops, and in severe cases heart rhythm can be affected. Compared with the early symptoms of Conn's syndrome, the long-term picture often involves repeated dips during illness or medication changes.
How is it to live with Conn's syndrome?
Living with Conn’s syndrome can feel like your body’s pressure system is set a notch too high—headaches, fatigue, muscle cramps, and frequent urination can drain energy and make work, exercise, and sleep less predictable. Many notice mood changes or foggy thinking when potassium runs low, and planning around clinic visits, blood tests, and medications becomes part of the routine. With treatment—often targeted medications or a curative surgery when one adrenal gland is the source—blood pressure and potassium usually stabilize, bringing steadier energy and fewer symptoms. Partners, family, and coworkers often feel the ripple effects before and after diagnosis, but clear communication and a shared plan for monitoring and care can make daily life smoother for everyone.
Treatment and drugs
Treatment for Conn’s syndrome focuses on controlling high blood pressure, correcting low potassium, and addressing the source of excess aldosterone. If a single adrenal nodule is making too much hormone, minimally invasive surgery to remove that adrenal gland can cure or greatly improve Conn’s syndrome in many people. When both adrenal glands are overactive, or if surgery isn’t a good fit, daily medicines called mineralocorticoid receptor blockers (such as spironolactone or eplerenone) help block aldosterone’s effects and lower blood pressure. Doctors sometimes recommend a combination of lifestyle changes and drugs, including reducing salt, maintaining a healthy weight, and using other blood pressure medicines as needed. A doctor may adjust your dose to balance benefits and side effects, and regular blood tests track potassium and kidney function over time.
Non-drug treatment
Non-drug approaches for Conn's syndrome focus on lowering blood pressure, supporting healthy potassium levels, and protecting the heart and kidneys in day-to-day life. Alongside medicines, non-drug therapies can make blood-pressure swings milder and reduce complications. Recognizing early symptoms of Conn's syndrome—like headaches, fatigue, or muscle cramps—can prompt earlier evaluation and lifestyle changes while your care plan is being set.
Cut back on salt to lower blood pressure strain in Conn's syndrome. Aim for about 1.5–2.0 g sodium (1,500–2,000 mg) per day, roughly 3.8–5.0 g salt (~3/4–1 tsp). Cooking at home and checking labels helps.
Include fruits, vegetables, beans, and dairy to support potassium in Conn's syndrome. Discuss amounts with your clinician if you have kidney issues or take potassium-sparing treatments. Sudden large supplements should be avoided unless prescribed.
A plant-forward, low-salt pattern supports steadier blood pressure. Focus on vegetables, fruits, whole grains, fish, and unsalted nuts. Limit processed foods, cured meats, and salty snacks.
If overweight, gradual loss of 5–10% body weight can lower blood pressure. Combine smaller portions with more movement. Seek dietitian support if progress stalls.
Your genes may have an impact on how drugs work for you
Medicines for Conn’s syndrome, like mineralocorticoid receptor blockers, can work differently depending on gene variants that affect drug targets, liver enzymes, and kidney handling of salts. These differences may shift the dose needed, side‑effect risk, and blood‑pressure response.
Pharmacological treatments
Medicines for Conn’s syndrome aim to block aldosterone’s effects, lower blood pressure, and bring potassium back into a safe range. They’re used long term for bilateral disease or when surgery isn’t an option, and short term to stabilize potassium before an operation. First-line medications are those doctors usually try first, based on safety, how well they work, and your other health needs. Your care team will monitor kidney function, blood pressure, and electrolytes regularly and adjust doses to fit your response.
This mineral blocker lowers blood pressure and raises potassium by countering excess aldosterone in Conn’s syndrome. It can cause breast tenderness, menstrual changes, or decreased libido; labs are checked to watch potassium and kidney function. Dosing may be increased or lowered gradually to find the lowest effective amount.
Similar to spironolactone but with fewer hormone-related side effects, this drug also blocks aldosterone’s action. It often needs twice-daily dosing and may be more costly, but many find it easier to tolerate. It’s a common choice if spironolactone causes problems.
This potassium-sparing diuretic helps when mineral blockers aren’t tolerated, by reducing sodium reabsorption and limiting potassium loss. It can be effective for blood pressure and potassium control in Conn’s syndrome. Blood tests track potassium to avoid levels that are too high.
Medicines like lisinopril or losartan help lower blood pressure and protect the heart and kidneys. They do not directly fix the aldosterone driver in Conn’s syndrome but can be useful add-ons. Potassium and kidney function need regular checks when these are combined with other therapies.
Genetic influences
Genetic factors can play a role in Conn's syndrome, but most cases aren’t inherited. In many people, the condition comes from gene changes that arise only in the adrenal nodule itself; these changes affect hormone production but aren’t passed on to children. A smaller share is due to inherited forms, often called familial hyperaldosteronism, which can show up at a younger age and sometimes affect both adrenal glands. Family history is one of the strongest clues to a genetic influence. In these families, early symptoms of Conn's syndrome—such as hard-to-control blood pressure or low potassium—may appear sooner in life. If several relatives have high blood pressure, strokes at a young age, or low potassium, your doctor may suggest genetic counseling or testing to clarify risk and guide treatment for you and your family.
Is Conn's syndrome genetic?
Genetics plays a smaller role in Conn’s syndrome than in many endocrine conditions. Most cases arise from acquired adrenal changes, but certain gene mutations in adrenal cells can drive hormone overproduction. Rarely, inherited forms cause early-onset or bilateral disease.
Pharmacogenetics—how genetics influence drug effects
In Conn's syndrome, genetics can shape treatment choices. If aldosterone overproduction comes from a single adrenal tumor with certain gene changes in cell channels or pumps, surgery to remove that gland often controls the condition. In some families, an inherited form—medically known as glucocorticoid‑remediable aldosteronism—responds to low‑dose corticosteroids, which can suppress the excess hormone and reduce the need for stronger blockers. Other inherited types tend to affect both adrenals, so long‑term treatment with mineralocorticoid receptor blockers (such as spironolactone or eplerenone) is usually preferred over surgery.
When medicines are used, genes may also influence drug response in Conn's syndrome. For example, eplerenone is cleared mainly by a liver enzyme system (often referred to as CYP3A4), and natural differences in these enzymes can change drug levels and side effects; even so, pharmacogenetic testing isn’t routinely recommended today. Genetics is only one factor, though; dose, other medications, kidney function, and diet also matter. If your blood pressure started young or there’s a strong family pattern, your care team may consider genetic testing to identify a familial form that can point to the most effective treatment.
Interactions with other conditions
Conn’s syndrome often travels with long-standing high blood pressure, heart rhythm problems, and kidney issues, and each can influence the others. Doctors call it a “comorbidity” when two conditions occur together. Too much aldosterone can thicken and stiffen blood vessel walls and strain the heart, which raises the chance of an irregular heartbeat, stroke, or heart enlargement even when blood pressure seems reasonably controlled. It can also harm the kidneys over time, leading to protein in the urine and chronic kidney disease, and the low potassium that comes with Conn’s syndrome may be worsened by certain water pills used for blood pressure. There’s also a link with sleep apnea and with insulin resistance, so some people with Conn’s syndrome are more likely to develop type 2 diabetes or find their glucose control harder than expected. This overlap can blur early symptoms of Conn’s syndrome, such as tiredness or muscle cramps from low potassium, because they can look similar to effects of other common conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described bouts of muscle weakness, severe headaches, and thirst that today sound like the early symptoms of Conn’s syndrome. A shopkeeper might have noticed blood pressure that stayed high despite multiple pills. Someone else may have cramped calves and need frequent bathroom trips, especially at night. Without lab tests, these stories were hard to connect, and many lived for years with “stubborn” hypertension that never quite made sense.
First described in the medical literature as a distinct condition in the 1950s by Dr. Jerome Conn, it linked a small adrenal growth to excess aldosterone and difficult-to-control blood pressure. Before that, doctors recognized high blood pressure and low potassium as separate findings. Dr. Conn’s report pulled the pieces together and showed that the adrenal gland could act like a stuck “dimmer switch,” turning hormone signals up when the body needed balance instead.
From these first observations, testing improved quickly. In the 1960s and 1970s, researchers refined blood and urine measurements to compare aldosterone with renin, which helped separate Conn’s syndrome from other causes of hypertension. Imaging such as CT scans in the late 20th century made it easier to spot tiny adrenal nodules. At the same time, selective sampling from the adrenal veins was developed to tell whether one gland or both were overproducing hormone, guiding decisions between surgery and medication.
Once considered rare, now recognized as a relatively common cause of secondary hypertension, Conn’s syndrome entered routine screening for people with resistant blood pressure, low potassium, or specific family patterns. As medical science evolved, doctors realized that many people have normal potassium levels, which meant earlier estimates missed a large group. Broader screening uncovered milder forms and showed that the condition can appear in different ways across ages and backgrounds.
Advances in genetics added another layer. In the 2010s, scientists identified changes in certain ion channels and pumps within adrenal cells that can trigger excess aldosterone. Some familial forms were mapped to inherited variants that raise risk across generations, while most cases remain sporadic. These discoveries did not change day-to-day care for everyone, but they clarified why some nodules make hormone and how the glands lose normal control.
With each decade, treatment became more tailored. Surgeons refined minimally invasive approaches to remove a single overactive adrenal nodule, often improving blood pressure and potassium quickly. For those with both glands affected, medicines that block aldosterone’s effect became safer and more widely used. Over time, the way Conn’s syndrome has been understood has changed, moving from a rare curiosity to a key diagnosis to consider when blood pressure resists standard therapy. Looking back helps explain why today’s guidelines emphasize targeted testing—so more people get the right treatment sooner.